Cargando…
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
SIMPLE SUMMARY: Medulloblastoma is the commonest malignant brain tumour of childhood. Disease relapse following maximal multi-modal therapy including upfront craniospinal irradiation (CSI) is almost always fatal and occurs in approximately 30% of patients. Importantly, patients rarely die of other c...
Autores principales: | Hill, Rebecca M., Plasschaert, Sabine L. A., Timmermann, Beate, Dufour, Christelle, Aquilina, Kristian, Avula, Shivaram, Donovan, Laura, Lequin, Maarten, Pietsch, Torsten, Thomale, Ulrich, Tippelt, Stephan, Wesseling, Pieter, Rutkowski, Stefan, Clifford, Steven C., Pfister, Stefan M., Bailey, Simon, Fleischhack, Gudrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750207/ https://www.ncbi.nlm.nih.gov/pubmed/35008290 http://dx.doi.org/10.3390/cancers14010126 |
Ejemplares similares
-
MEDB-17. Re-irradiation for recurrent medulloblastoma in a matched cohort: Advantageous especially in patients without resection
por: Adolph, Jonas E, et al.
Publicado: (2022) -
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 Study
por: Gaab, Christine, et al.
Publicado: (2022) -
MEDB-38. Significance of CSF cytology and neurologic deterioration in relapsed medulloblastomas in the German HIT-REZ-97/-2005 Studies and the HIT-REZ-Register
por: Tschirner, Sebastian, et al.
Publicado: (2022) -
Relapse patterns and outcome after relapse in standard risk medulloblastoma: a report from the HIT-SIOP-PNET4 study
por: Sabel, Magnus, et al.
Publicado: (2016) -
EPEN-06. CHEMOTHERAPY OF RECURRENT EPENDYMOMA: LONG-TERM RESPONSE ONLY IN FEW CASES
por: Adolph, Jonas, et al.
Publicado: (2020)